• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Clearance by the liver in cirrhosis. II. Characterization of propranolol uptake with the multiple-indicator dilution technique.

作者信息

Gariépy L, Fenyves D, Kassissia I, Villeneuve J P

机构信息

Division of Hepatology, Hôpital Saint-Luc, Montréal, Quebec, Canada.

出版信息

Hepatology. 1993 Oct;18(4):823-31. doi: 10.1002/hep.1840180412.

DOI:10.1002/hep.1840180412
PMID:8406355
Abstract

We studied the steady-state hepatic extraction and single-pass hepatic uptake of propranolol in isolated perfused livers from normal rats and compared these values with those of rats with carbon tetrachloride-induced cirrhosis, rats treated with chlorpromazine (an inhibitor of propranolol metabolism) and rats with acute liver injury. The kinetics of propranolol transport in the liver were characterized by means of the multiple-indicator dilution technique, and estimates of cellular influx, efflux and sequestration rate constants were obtained with a computer fit to the model of Goresky. The outflow pattern of propranolol in the hepatic veins was then resolved into throughput material, which had swept past the hepatocytes along with albumin, and returning material, which had entered the cells but returned in the outflow after escaping metabolic sequestration. The steady-state extraction of propranolol was significantly decreased in the three experimental groups compared with that in controls, but the outflow profile differed within each group. In cirrhotic animals, influx was markedly decreased and the sequestration rate constant remained unchanged; most of the propranolol in the outflow consisted of throughput material. In rats treated with chlorpromazine, the sequestration rate constant was decreased, and propranolol in the outflow was mainly returning material. In rats with acute liver injury, both influx and sequestration rate constants were decreased. Indicator dilution curves for nonsequestered tracers showed a decreased transit time for red blood cells and abnormal diffusion of albumin and sucrose into the space of Disse in cirrhotic rats compared with the other groups.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

相似文献

1
Clearance by the liver in cirrhosis. II. Characterization of propranolol uptake with the multiple-indicator dilution technique.
Hepatology. 1993 Oct;18(4):823-31. doi: 10.1002/hep.1840180412.
2
Clearance by the liver in cirrhosis. III. Propranolol uptake by the isolated perfused human liver.
Can J Physiol Pharmacol. 1996 Dec;74(12):1327-32.
3
Clearance by the liver in cirrhosis. I. Relationship between propranolol metabolism in vitro and its extraction by the perfused liver in the rat.肝硬化时肝脏的清除率。I. 大鼠体外普萘洛尔代谢与其经灌注肝脏摄取之间的关系。
Hepatology. 1993 Feb;17(2):301-6.
4
Carrier-mediated uptake and excretion of bromosulfophthalein-glutathione in perfused rat liver: a multiple indicator dilution study.载体介导的溴磺酞谷胱甘肽在灌注大鼠肝脏中的摄取和排泄:一项多指标稀释研究。
Hepatology. 1995 Oct;22(4 Pt 1):1188-207. doi: 10.1002/hep.1840220427.
5
Dose-dependent hepatic handling of l-propranolol determined by multiple indicator dilution method: influence of tissue binding of l-propranolol on its hepatic elimination.
Biol Pharm Bull. 1993 Oct;16(10):1019-24. doi: 10.1248/bpb.16.1019.
6
Hepatic artery flow and propranolol metabolism in perfused cirrhotic rat liver.灌注肝硬化大鼠肝脏中的肝动脉血流与普萘洛尔代谢
J Pharmacol Exp Ther. 1999 Jun;289(3):1553-8.
7
Increased sensitivity of propranolol clearance to reduced oxygen delivery in the isolated perfused cirrhotic rat liver.在离体灌注的肝硬化大鼠肝脏中,普萘洛尔清除率对氧输送减少的敏感性增加。
Gastroenterology. 1996 Oct;111(4):1039-48. doi: 10.1016/s0016-5085(96)70073-2.
8
Propranolol metabolism by isolated hepatocytes from normal and cirrhotic rat livers: the effect of albumin.
Can J Physiol Pharmacol. 1990 Jun;68(6):657-62. doi: 10.1139/y90-098.
9
The influence of glucagon on the hepatic transport of taurocholate in isolated perfused rat liver: kinetic analysis by the multiple indicator dilution technique.胰高血糖素对离体灌注大鼠肝脏中牛磺胆酸盐肝转运的影响:用多指示剂稀释技术进行动力学分析
Biol Pharm Bull. 1993 Aug;16(8):791-5. doi: 10.1248/bpb.16.791.
10
Demonstration of rapid entry and a cellular binding space for salicylamide in perfused rat liver: a multiple indicator dilution study.水杨酰胺在灌注大鼠肝脏中的快速进入及细胞结合空间的证明:一项多指示剂稀释研究。
J Pharmacol Exp Ther. 1994 Jul;270(1):285-95.

引用本文的文献

1
Pharmacokinetic drug interactions in liver disease: An update.肝病中的药代动力学药物相互作用:最新进展。
World J Gastroenterol. 2016 Jan 21;22(3):1260-78. doi: 10.3748/wjg.v22.i3.1260.
2
The influence of old age and poloxamer-407 on the hepatic disposition of diazepam in the isolated perfused rat liver.年龄和泊洛沙姆 407 对离体大鼠肝中地西泮肝处置的影响。
Pharmacology. 2012;90(5-6):233-41. doi: 10.1159/000341724. Epub 2012 Sep 19.
3
The hepatic sinusoid in aging and cirrhosis: effects on hepatic substrate disposition and drug clearance.
衰老和肝硬化中的肝血窦:对肝脏底物处置和药物清除的影响。
Clin Pharmacokinet. 2005;44(2):187-200. doi: 10.2165/00003088-200544020-00004.
4
Interpretation of simultaneous measurements of hepatic extraction fractions of indocyanine green and sorbitol: evidence of hepatic shunts and capillarization?吲哚菁绿和山梨醇肝提取分数同步测量的解读:肝内分流和毛细血管化的证据?
Dig Dis Sci. 2000 Feb;45(2):359-65. doi: 10.1023/a:1005476913311.
5
Lidocaine and monoethylglycinexylidide serum determinations to analyze liver function of cirrhotic patients after oral administration.
Dig Dis Sci. 1999 Apr;44(4):789-95. doi: 10.1023/a:1026630313038.
6
Membrane transport in hepatic clearance of drugs. I: Extended hepatic clearance models incorporating concentration-dependent transport and elimination processes.
Pharm Res. 1997 Jun;14(6):774-9. doi: 10.1023/a:1012106623696.
7
Clinical pharmacokinetic and pharmacodynamic considerations in patients with liver disease. An update.肝病患者的临床药代动力学和药效学考量。最新进展。
Clin Pharmacokinet. 1995 Nov;29(5):370-91. doi: 10.2165/00003088-199529050-00005.